MedsFacts.com - the Next-Generation Reference for Medication Safety.
MedsFacts is a unique online community for patients, health care providers, and medical researchers.
Our goal is to provide valuable information for the 60% of Americans (and others worldwide) currently taking prescription drugs.
Easy to use online research interface helps you quickly assess the benefits and potential danger of various treatments.
Analysis of the latest Food & Drug Administration data covers over 18 million drug side effect profiles.
Interactive tools to allow you to collaborate with others to learn more about medications.
Make more informed treatment decisions knowing you consulted MedsFacts analytics - medical research studies that scrutinize drug safety reports.
MedsFacts is a free service, as we believe the usefulness of our platform scales as more people interact with our service.

About this MedsFacts analysis covering adverse side effect reports of LOSARTAN patients who developed PETECHIAE.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 3 individuals taking LOSARTAN reported PETECHIAE to the FDA. A total of 2341 LOSARTAN drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between LOSARTAN and PETECHIAE. In doing so, we compare LOSARTAN with other drugs that cause PETECHIAE, to help you evaluate whether or not LOSARTAN causes PETECHIAE. Likewise, this page shows the most highly-reported side effects of LOSARTAN, so you can see if PETECHIAE ranks among LOSARTAN's most well-known side effects.
Summary Statistics
Reports of LOSARTAN causing PETECHIAE: 3
Reports of any side effect of LOSARTAN : 2341
Percentage of LOSARTAN patients where PETECHIAE is a reported side effect: 0.1282%

FDA reports of any drug causing PETECHIAE : 3958
Average percentage for all medicated patients where PETECHIAE is reported as a complication: 0.0248%

Physician opinion on LOSARTAN as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing LOSARTAN:
HYPERTENSION ( 648 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 91 patients )
DRUG USE FOR UNKNOWN INDICATION ( 79 patients )
BLOOD PRESSURE ( 44 patients )
BLOOD PRESSURE ABNORMAL ( 26 patients )
CARDIAC DISORDER ( 22 patients )
BLOOD PRESSURE INCREASED ( 13 patients )
PROPHYLAXIS ( 10 patients )
ESSENTIAL HYPERTENSION ( 6 patients )
CARDIAC REHABILITATION THERAPY ( 5 patients )
DIABETES MELLITUS ( 4 patients )
RENAL DISORDER ( 4 patients )
CEREBROVASCULAR DISORDER ( 3 patients )
RENAL FAILURE ( 3 patients )
CARDIAC FAILURE ( 3 patients )
CARDIAC FAILURE CONGESTIVE ( 3 patients )
NEPHROTIC SYNDROME ( 2 patients )
MYOCARDIAL ISCHAEMIA ( 2 patients )
AORTIC VALVE INCOMPETENCE ( 2 patients )
PAIN ( 2 patients )
BLOOD CHOLESTEROL INCREASED ( 2 patients )
PROTEINURIA ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
ATRIAL FIBRILLATION ( 1 patients )
DRUG THERAPY ( 1 patients )
BLOOD POTASSIUM DECREASED ( 1 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
RHEUMATOID ARTHRITIS ( 1 patients )
HYPERTENSIVE NEPHROPATHY ( 1 patients )
SUICIDE ATTEMPT ( 1 patients )
INFARCTION ( 1 patients )
CARDIAC FAILURE ACUTE ( 1 patients )
LIPIDS INCREASED ( 1 patients )
DRESSLER'S SYNDROME ( 1 patients )
GLAUCOMA ( 1 patients )
BLOOD PRESSURE INADEQUATELY CONTROLLED ( 1 patients )
BLOOD PRESSURE MANAGEMENT ( 1 patients )
RHINITIS ( 1 patients )
INTENTIONAL OVERDOSE ( 1 patients )
MYOCARDIAL INFARCTION ( 1 patients )
CARDIOMEGALY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with PETECHIAE:

ASPIRIN (346 patients)
NPLATE (293 patients)
PREDNISONE (189 patients)
OMEPRAZOLE (184 patients)
ACETAMINOPHEN (176 patients)
MAGNEVIST (166 patients)
PREDNISOLONE (161 patients)
FUROSEMIDE (157 patients)
DEXAMETHASONE (152 patients)
FOSAMAX (147 patients)
LASIX (147 patients)
METHOTREXATE (143 patients)
PLAVIX (142 patients)
SYNTHROID (124 patients)
SIMVASTATIN (117 patients)
FOLIC ACID (116 patients)
NEXIUM (114 patients)
LEVOTHYROXINE SODIUM (113 patients)
LISINOPRIL (110 patients)
ALLOPURINOL (107 patients)
COUMADIN (104 patients)
HEPARIN (104 patients)
NEURONTIN (102 patients)
CARBOPLATIN (96 patients)
LIPITOR (93 patients)
CYTARABINE (91 patients)
ATENOLOL (90 patients)
POTASSIUM CHLORIDE (88 patients)
HUMIRA (86 patients)
WARFARIN SODIUM (85 patients)
VANCOMYCIN (84 patients)
DECADRON (84 patients)
REVLIMID (82 patients)
LORAZEPAM (82 patients)
VIOXX (79 patients)
NORVASC (78 patients)
NEUPOGEN (77 patients)
PRILOSEC (77 patients)
AMOXICILLIN (77 patients)
CYCLOPHOSPHAMIDE (77 patients)
HYDROCHLOROTHIAZIDE (76 patients)
AREDIA (74 patients)
ZOMETA (72 patients)
AMBIEN (71 patients)
GABAPENTIN (70 patients)
DIGOXIN (69 patients)
XANAX (68 patients)
ENBREL (68 patients)
LAMICTAL (66 patients)
ZOCOR (66 patients)
OXYCONTIN (66 patients)
LEVAQUIN (65 patients)
METOCLOPRAMIDE (65 patients)
GLEEVEC (65 patients)
ONDANSETRON (64 patients)
SINGULAIR (64 patients)
BENADRYL (62 patients)
DIOVAN (62 patients)
ZOFRAN (62 patients)
AVELOX (61 patients)
CELEBREX (61 patients)
LEXAPRO (60 patients)
VICODIN (60 patients)
ACYCLOVIR (60 patients)
CLARITHROMYCIN (60 patients)
MULTI-VITAMINS (60 patients)
REMICADE (60 patients)
ATIVAN (59 patients)
CRESTOR (59 patients)
IBUPROFEN (59 patients)
CIPROFLOXACIN (58 patients)
AVASTIN (57 patients)
METFORMIN HCL (57 patients)
LYRICA (57 patients)
CYCLOSPORINE (57 patients)
PREVACID (56 patients)
VITAMIN D (56 patients)
DIFLUCAN (55 patients)
SOLU-MEDROL (55 patients)
VELCADE (55 patients)
PREDNISONE TAB (54 patients)
ZOLOFT (54 patients)
TRAMADOL HCL (54 patients)
CYMBALTA (54 patients)
SPIRONOLACTONE (54 patients)
PROTONIX (52 patients)
VALPROATE SODIUM (52 patients)
BACTRIM (52 patients)
KEPPRA (52 patients)
TOPROL-XL (51 patients)
PERCOCET (51 patients)
FENTANYL (51 patients)
INSULIN (51 patients)
NEULASTA (51 patients)
PHENYTOIN (50 patients)
PROCRIT (50 patients)
VOLTAREN (49 patients)
SUTENT (48 patients)
ALBUTEROL (48 patients)
FLUCONAZOLE (47 patients)
FAMOTIDINE (47 patients)
TEMODAL (47 patients)
AMLODIPINE (47 patients)
CORTICOSTEROIDS (46 patients)
PRADAXA (44 patients)
DURAGESIC-100 (43 patients)
EXJADE (43 patients)
ZYRTEC (42 patients)
UNSPECIFIED GADOLINIUM (42 patients)
CISPLATIN (42 patients)
AMLODIPINE BESYLATE (42 patients)
OXYCODONE HCL (42 patients)
BISOPROLOL FUMARATE (42 patients)
ETOPOSIDE (42 patients)
ALTACE (42 patients)
RAMIPRIL (41 patients)
TOPAMAX (41 patients)
ALPRAZOLAM (41 patients)
ENALAPRIL MALEATE (41 patients)
METOPROLOL TARTRATE (41 patients)
LANSOPRAZOLE (41 patients)
VINCRISTINE (40 patients)
TYLENOL (CAPLET) (40 patients)
CLOZARIL (39 patients)
GEMZAR (38 patients)
LANTUS (38 patients)
AUGMENTIN '125' (38 patients)
CEPHALEXIN (38 patients)
HEPARIN SODIUM INJECTION (38 patients)
TEGRETOL (38 patients)
ALLEGRA (38 patients)
LACTULOSE (37 patients)
INTEGRILIN (37 patients)
PREMARIN (37 patients)
SERTRALINE HYDROCHLORIDE (37 patients)
PARACETAMOL (37 patients)
FLUOROURACIL (37 patients)
PANTOPRAZOLE (36 patients)
PROVIGIL (36 patients)
VIDAZA (36 patients)
RITUXIMAB (36 patients)
MORPHINE (36 patients)
HEPARIN SODIUM (36 patients)
TRAZODONE HCL (35 patients)
ENOXAPARIN SODIUM (34 patients)
METHYLPREDNISOLONE (34 patients)
CELEXA (34 patients)
CALCIUM (34 patients)
HYDROCORTISONE (34 patients)
METRONIDAZOLE (34 patients)
FLAGYL (34 patients)
TAXOL (33 patients)
METOPROLOL (33 patients)
FISH OIL (33 patients)
ATORVASTATIN CALCIUM (33 patients)
RANITIDINE (33 patients)
SEROQUEL (33 patients)
PANTOPRAZOLE SODIUM (33 patients)
METOPROLOL SUCCINATE (33 patients)
TYLENOL (32 patients)
CLINDAMYCIN (32 patients)
ZANTAC (32 patients)
WARFARIN (31 patients)
CALCIUM CARBONATE (31 patients)
COREG (31 patients)
PROZAC (31 patients)
FLEXERIL (31 patients)
KEFLEX (31 patients)
REGLAN (31 patients)
SINTROM (31 patients)
MOTRIN (30 patients)
PROMACTA (30 patients)
LEVOFLOXACIN (30 patients)
MIRALAX (30 patients)
LORTAB (30 patients)
VALIUM (30 patients)
LAMISIL (30 patients)
VITAMIN B-12 (30 patients)
PEG-INTRON (30 patients)
ALDACTONE (30 patients)
CARBAMAZEPINE (30 patients)
ZESTRIL (29 patients)
CLONAZEPAM (29 patients)
ZITHROMAX (29 patients)
DEXAMETHASONE TAB (29 patients)
EPOGEN (29 patients)
EFFEXOR (29 patients)
MORPHINE SULFATE (29 patients)
ACTONEL (29 patients)
SULFAMETHOXAZOLE (29 patients)
LOVENOX (29 patients)
GENTAMICIN (29 patients)
PLATELETS (29 patients)
RED BLOOD CELLS (28 patients)
CEFTRIAXONE (28 patients)
DEPAKOTE (28 patients)
KYTRIL (28 patients)
ACTEMRA (28 patients)
ACTOS (28 patients)
CIPRO (28 patients)
AMOXICILLIN AND CLAVULANATE POTASSIUM (28 patients)
NEORAL (28 patients)
XELODA (28 patients)
ELIDEL (28 patients)
MAGNESIUM OXIDE (27 patients)
DIPHENHYDRAMINE HCL (27 patients)
CARVEDILOL (27 patients)
RISPERIDONE (27 patients)
ASCORBIC ACID (27 patients)
GLUCOPHAGE (27 patients)
Most common side effects for patients taking LOSARTAN:
DYSPNOEA (143 patients)
NAUSEA (142 patients)
DIZZINESS (117 patients)
DRUG INEFFECTIVE (117 patients)
ASTHENIA (113 patients)
HEADACHE (102 patients)
DIARRHOEA (97 patients)
PAIN (94 patients)
BLOOD PRESSURE INCREASED (93 patients)
FATIGUE (88 patients)
HYPERTENSION (86 patients)
PAIN IN EXTREMITY (80 patients)
ANXIETY (77 patients)
OEDEMA PERIPHERAL (76 patients)
RENAL FAILURE ACUTE (74 patients)
MALAISE (72 patients)
WEIGHT DECREASED (70 patients)
FALL (70 patients)
VOMITING (70 patients)
DEATH (68 patients)
CHEST PAIN (67 patients)
GAIT DISTURBANCE (66 patients)
ARTHRALGIA (65 patients)
PNEUMONIA (64 patients)
MYALGIA (63 patients)
DECREASED APPETITE (62 patients)
HYPOTENSION (62 patients)
COUGH (61 patients)
PYREXIA (59 patients)
SOMNOLENCE (59 patients)
DEPRESSION (58 patients)
URINARY TRACT INFECTION (58 patients)
INSOMNIA (56 patients)
DRUG INTERACTION (56 patients)
BACK PAIN (55 patients)
ANAEMIA (53 patients)
PRURITUS (52 patients)
VISION BLURRED (52 patients)
MUSCLE SPASMS (51 patients)
WEIGHT INCREASED (48 patients)
VISUAL IMPAIRMENT (48 patients)
FEELING ABNORMAL (48 patients)
BLOOD GLUCOSE INCREASED (48 patients)
CONFUSIONAL STATE (47 patients)
MYOCARDIAL INFARCTION (45 patients)
HYPOAESTHESIA (42 patients)
ABDOMINAL PAIN (41 patients)
ATRIAL FIBRILLATION (41 patients)
BLOOD CREATININE INCREASED (40 patients)
ERYTHEMA (39 patients)
ABDOMINAL PAIN UPPER (38 patients)
CEREBROVASCULAR ACCIDENT (38 patients)
RENAL FAILURE (38 patients)
CARDIAC FAILURE (38 patients)
RENAL IMPAIRMENT (37 patients)
CONSTIPATION (37 patients)
INJURY (35 patients)
PLEURAL EFFUSION (35 patients)
RASH (34 patients)
ALOPECIA (34 patients)
DRUG HYPERSENSITIVITY (34 patients)
MUSCULAR WEAKNESS (34 patients)
DIABETES MELLITUS (32 patients)
PARAESTHESIA (32 patients)
CONVULSION (32 patients)
BALANCE DISORDER (31 patients)
BLOOD CHOLESTEROL INCREASED (31 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (30 patients)
CARDIAC FAILURE CONGESTIVE (30 patients)
HYPOGLYCAEMIA (30 patients)
SWELLING (30 patients)
TREMOR (30 patients)
SYNCOPE (30 patients)
NERVOUSNESS (30 patients)
ABDOMINAL DISTENSION (29 patients)
LOSS OF CONSCIOUSNESS (29 patients)
AGITATION (29 patients)
CONDITION AGGRAVATED (29 patients)
DEHYDRATION (29 patients)
ABDOMINAL DISCOMFORT (28 patients)
CARDIOMEGALY (28 patients)
VERTIGO (28 patients)
INFECTION (28 patients)
CARDIAC ARREST (28 patients)
PALPITATIONS (27 patients)
CHILLS (27 patients)
RENAL FAILURE CHRONIC (26 patients)
HYPERGLYCAEMIA (26 patients)
PULMONARY EMBOLISM (25 patients)
HYPERTENSIVE EMERGENCY (25 patients)
SEPSIS (25 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (25 patients)
DYSGEUSIA (25 patients)
HAEMOGLOBIN DECREASED (24 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (24 patients)
DYSPHAGIA (24 patients)
PULMONARY OEDEMA (24 patients)
COMPLETED SUICIDE (23 patients)
HYPONATRAEMIA (23 patients)
HAEMATURIA (23 patients)
ARRHYTHMIA (23 patients)
ASTHMA (23 patients)
DYSPEPSIA (23 patients)
ABASIA (22 patients)
TACHYCARDIA (22 patients)
SURGERY (22 patients)
HALLUCINATION (22 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (22 patients)
PROTEINURIA (22 patients)
SKIN ULCER (22 patients)
HYPERKALAEMIA (22 patients)
DYSPHONIA (21 patients)
HEART RATE INCREASED (21 patients)
HYPERHIDROSIS (21 patients)
THROMBOCYTOPENIA (21 patients)
BONE PAIN (21 patients)
URINARY INCONTINENCE (21 patients)
RESPIRATORY FAILURE (20 patients)
LACTIC ACIDOSIS (20 patients)
EMOTIONAL DISTRESS (20 patients)
HYPOKALAEMIA (20 patients)
SLEEP DISORDER (20 patients)
GASTROINTESTINAL HAEMORRHAGE (20 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (20 patients)
DRY MOUTH (20 patients)
NEUROPATHY PERIPHERAL (20 patients)
AMNESIA (19 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (19 patients)
DISEASE PROGRESSION (19 patients)
HYPERSENSITIVITY (19 patients)
OSTEOARTHRITIS (18 patients)
BLOOD PRESSURE DECREASED (18 patients)
OSTEONECROSIS OF JAW (18 patients)
SKIN DISCOLOURATION (18 patients)
CHEST DISCOMFORT (18 patients)
FIBROMYALGIA (18 patients)
NASOPHARYNGITIS (18 patients)
RECTAL HAEMORRHAGE (18 patients)
HAEMATEMESIS (18 patients)
ARTHRITIS (18 patients)
RHINORRHOEA (17 patients)
OEDEMA (17 patients)
DYSKINESIA (17 patients)
FEAR (17 patients)
EPISTAXIS (17 patients)
STOMATITIS (17 patients)
INCORRECT DOSE ADMINISTERED (17 patients)
MUSCULOSKELETAL PAIN (17 patients)
OFF LABEL USE (17 patients)
MULTI-ORGAN FAILURE (17 patients)
DRY EYE (17 patients)
ACUTE MYOCARDIAL INFARCTION (16 patients)
ALANINE AMINOTRANSFERASE INCREASED (16 patients)
UNEVALUABLE EVENT (16 patients)
HYPOCALCAEMIA (16 patients)
CARDIAC DISORDER (16 patients)
CATARACT (16 patients)
BLINDNESS (16 patients)
MEMORY IMPAIRMENT (16 patients)
BURNING SENSATION (15 patients)
SPINAL OSTEOARTHRITIS (15 patients)
HAEMATOCHEZIA (15 patients)
ARTHROPATHY (15 patients)
INFLUENZA (15 patients)
PRURITUS GENERALISED (15 patients)
JOINT SWELLING (15 patients)
IRRITABILITY (15 patients)
BRONCHITIS (15 patients)
DISTURBANCE IN ATTENTION (15 patients)
SKIN DISORDER (14 patients)
WHITE BLOOD CELL COUNT INCREASED (14 patients)
OSTEOMYELITIS (14 patients)
TRANSIENT ISCHAEMIC ATTACK (14 patients)
VISUAL ACUITY REDUCED (14 patients)
GASTRITIS (14 patients)
WHITE BLOOD CELL COUNT DECREASED (14 patients)
DYSPNOEA EXERTIONAL (14 patients)
TINNITUS (14 patients)
BLISTER (14 patients)
GASTRIC DISORDER (14 patients)
DRUG LEVEL INCREASED (14 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (14 patients)
GLOMERULAR FILTRATION RATE DECREASED (14 patients)
OBESITY (13 patients)
DEPRESSED MOOD (13 patients)
CARPAL TUNNEL SYNDROME (13 patients)
DISORIENTATION (13 patients)
ANHEDONIA (13 patients)
INFARCTION (13 patients)
CARDIOVASCULAR DISORDER (13 patients)
BLOOD UREA INCREASED (13 patients)
THROMBOSIS (13 patients)
DRUG INTOLERANCE (13 patients)
SINUS TACHYCARDIA (13 patients)
DEEP VEIN THROMBOSIS (13 patients)
RHABDOMYOLYSIS (13 patients)
HYPOPHAGIA (13 patients)
NEUTROPENIA (12 patients)
RASH ERYTHEMATOUS (12 patients)
NECK PAIN (12 patients)
INTERVERTEBRAL DISC PROTRUSION (12 patients)
GLYCOSYLATED HAEMOGLOBIN INCREASED (12 patients)
PRESYNCOPE (12 patients)
MENTAL STATUS CHANGES (12 patients)
MUSCULOSKELETAL STIFFNESS (12 patients)
EMOTIONAL DISORDER (12 patients)
HYPERLIPIDAEMIA (12 patients)
BRADYCARDIA (12 patients)
FLUSHING (12 patients)
NEPHROLITHIASIS (12 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for LOSARTAN


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about PETECHIAE and LOSARTAN, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking LOSARTAN, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in LOSARTAN. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for LOSARTAN experts. If you are a healthcare provider experienced in prescribing LOSARTAN, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use